Search for: "Eli Lilly " Results 861 - 880 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Nov 2013, 10:01 pm by Cathy Siegner
Optaflexx, sold by Eli Lilly’s Elanco animal-health unit, is considered less effective than Zilmax. [read post]
4 Nov 2013, 7:52 pm by Aaron Barkoff
Eli Lilly and Co., IPR2013-00356, where the Board found that the filing of a second complaint in the second of two prior lawsuits did not reset the time for filing a petition. [read post]
28 Oct 2013, 1:12 pm by Justin K. Beyer
  On August 14, 2013, a grand jury in the Southern District of Indiana returned a superseding indictment against Guoqing Cao (“Cao”) and Shuyu “Dan” Li (“Li”), stemming from Cao and Li’s alleged multi-year plot to steal Eli Lilly trade secrets and transfer those secrets to one of Eli Lilly’s Chinese-based competitors, Jiangsu Hengrui Medicine Co., Ltd., located in Shanghai, China. [read post]
25 Oct 2013, 1:50 am by Nietzer
In December, 2012, the SEC released its FCPA enforcement action against Eli Lilly and Company (Lilly). [read post]
22 Oct 2013, 11:59 am by Mark Zamora
Byetta (April 28, 2005) (Amylin / Ely Lilly)2. [read post]
20 Oct 2013, 6:05 am by Gene Quinn
In fact, Eli Lilly lost its bid to have its dispute with Genentech and City of Hope heard in the Northern District of California despite having a forum selection clause in the governing contract that stated the parties would litigate any dispute in the Northern District of California. [read post]
20 Oct 2013, 6:05 am by Gene Quinn
In fact, Eli Lilly lost its bid to have its dispute with Genentech and City of Hope heard in the Northern District of California despite having a forum selection clause in the governing contract that stated the parties would litigate any dispute in the Northern District of California. [read post]
16 Oct 2013, 4:30 am by Steve McConnell
Eli Lilly & Co., 44 Cal. 3d 1103 (1988), the court declined to apply the American Pipe rule to a personal-injury mass-tort action case arising from alleged product defects and negligence relating to a prescription drug. [read post]
14 Oct 2013, 4:15 am by Scott A. McKeown
Eli Lilly & Company (IPR2013-00356) A week back, a petitioner (IPR2014-00008) has challenged the retroactive nature of 315(b) as it applies to complaints served prior to enactment of the statute. [read post]
13 Oct 2013, 1:05 pm
“20k is small change, and they can justify it easily if they want to be at the table,” one professor wrote to the other after an Eli Lilly representative objected to the price. [read post]
13 Oct 2013, 12:21 pm by Steve Brachmann
Not all of Eli Lilly and Company’s developments are strictly related to human health. [read post]
13 Oct 2013, 12:21 pm by Steve Brachmann
Not all of Eli Lilly and Company’s developments are strictly related to human health. [read post]